NASDAQ:SVRA
Savara Inc Stock Company Profile
$4.81
+0.0200 (+0.418%)
At Close: Apr 19, 2024
Information
Building III, Suite 201 6836 Bee Cave Road
Austin TX 78746
512 614 1848
www.savarapharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.